Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study - Ferguson, JJ; Antman, EM; Bates, ER (Am Heart J, 2003)
et al.